Among the 20 cancer types examined in this study, more than half of patients with thyroid cancer, lung cancer, and prostate cancer showed medium to high levels of PLK4 protein expression in IHC staining results using two antibodies (HPA035026, HPA043198). Here, PLK4 is linked to prostate cancer.